Orthofix International Announces First Annual Investor Day

* Reuters is not responsible for the content in this press release.

Tue Sep 2, 2008 2:47pm EDT

BOSTON--(Business Wire)--
Orthofix International N.V. (NASDAQ: OFIX) (the Company) announced
today that it will hold its First Annual Investor Day on Monday,
September 8th at Le Parker Meridien in New York City.

   The event will begin at 8:30 AM Eastern Time with a display of key
products from its business units. President and CEO Alan Milinazzo
will be the first to address the audience at 9:00 AM, followed by
presentations from additional members of the Company's management
team.

   Orthofix will also webcast the presentations in their entirety,
beginning at 9:00 AM. Interested parties may access the webcast by
going to www.orthofix.com and clicking on Investors, and then Events &
Presentations.

   About Orthofix

   Orthofix International N.V., a global diversified medical device
company, offers a broad line of minimally invasive surgical, and
non-surgical, products for the spine, orthopedic, and sports medicine
market sectors that address the lifelong bone-and-joint health needs
of patients of all ages-helping them achieve a more active and mobile
lifestyle. Orthofix's products are widely distributed around the world
to orthopedic surgeons and patients via Orthofix's sales
representatives and its subsidiaries, including BREG, Inc. and
Blackstone Medical, Inc., and via partnerships with other leading
orthopedic product companies. In addition, Orthofix is collaborating
in R&D partnerships with leading medical institutions such as the
Orthopedic Research and Education Foundation, Rutgers University, the
Cleveland Clinic Foundation, Texas Scottish Rite Hospital for Children
and National Osteoporosis Institute. For more information about
Orthofix, please visit www.orthofix.com.

Orthofix International N.V.
Dan Yarbrough, 617-912-2903
Vice President of Investor Relations
danyarbrough@orthofix.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.